Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Michael Conn

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 19, 2006
Specializations of a G-protein-coupled receptor that appear to aid with detection of frequency-modulated signals from its ligandJo Ann Janovick, Shaun P Brothers, Paul E Knollman, et al.
Journal of Biomolecular Screening|May 4, 2013
High-throughput screen for pharmacoperones of the vasopressin type 2 receptorP Michael Conn, Emery Smith, Peter Hodder, et al.
Molecular and Cellular Endocrinology|December 5, 2003
Regulation of FSHbeta and GnRH receptor gene expression in activin receptor II knockout male miceT Rajendra Kumar, Julio Agno, Jo Ann Janovick, et al.
Assay and Drug Development Technologies|May 17, 2014
A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptorP Michael Conn, Emery Smith, Timothy Spicer, et al.
Plos One|August 3, 2017
Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling biasJo Ann Janovick, Timothy P Spicer, Thomas D Bannister, et al.
The Journal of Biological Chemistry|February 23, 2002
Two defective heterozygous luteinizing hormone receptors can rescue hormone actionChangWoo Lee, Inhae Ji, KiSung Ryu, et al.
Molecular Endocrinology (Baltimore, Md.)|May 19, 2012
Rescue of misrouted GnRHR mutants reveals its constitutive activityJo Ann Janovick, Irina D Pogozheva, Henry I Mosberg, et al.
Molecular and Cellular Endocrinology|June 1, 2002
Structural determinants in the second intracellular loop of the human follicle-stimulating hormone receptor are involved in G(s) protein activationCarlos Timossi, David Maldonado, Andrea Vizcaíno, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humansAlfredo Leaños-Miranda, Alfredo Ulloa-Aguirre, Tae H Ji, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptorJo Ann Janovick, Mark Goulet, Eugene Bush, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 19, 2006
Specializations of a G-protein-coupled receptor that appear to aid with detection of frequency-modulated signals from its ligandJo Ann Janovick, Shaun P Brothers, Paul E Knollman, et al.
Journal of Biomolecular Screening|May 4, 2013
High-throughput screen for pharmacoperones of the vasopressin type 2 receptorP Michael Conn, Emery Smith, Peter Hodder, et al.
Molecular and Cellular Endocrinology|December 5, 2003
Regulation of FSHbeta and GnRH receptor gene expression in activin receptor II knockout male miceT Rajendra Kumar, Julio Agno, Jo Ann Janovick, et al.
Assay and Drug Development Technologies|May 17, 2014
A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptorP Michael Conn, Emery Smith, Timothy Spicer, et al.
Plos One|August 3, 2017
Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling biasJo Ann Janovick, Timothy P Spicer, Thomas D Bannister, et al.
The Journal of Biological Chemistry|February 23, 2002
Two defective heterozygous luteinizing hormone receptors can rescue hormone actionChangWoo Lee, Inhae Ji, KiSung Ryu, et al.
Molecular Endocrinology (Baltimore, Md.)|May 19, 2012
Rescue of misrouted GnRHR mutants reveals its constitutive activityJo Ann Janovick, Irina D Pogozheva, Henry I Mosberg, et al.
Molecular and Cellular Endocrinology|June 1, 2002
Structural determinants in the second intracellular loop of the human follicle-stimulating hormone receptor are involved in G(s) protein activationCarlos Timossi, David Maldonado, Andrea Vizcaíno, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humansAlfredo Leaños-Miranda, Alfredo Ulloa-Aguirre, Tae H Ji, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptorJo Ann Janovick, Mark Goulet, Eugene Bush, et al.
Pageof 11